Lecanemab, the New FDA-approved Drug for Patients with Early Alzheimer’s Disease (Segment 1 of 2)
Watch Dr. Keith Vossel's live interview on July 6th, with KCAL-LA Evening News, about the benefits of the treatment, possible side effects, and expected out-of-pocket costs with CMS coverage for patients eligible for Leqembi, a fully FDA-approved Alzheimer’s drug.
Related Articles
Article
A More Inclusive Framework for Alzheimer’s Disease
The Easton Center, ELHA Lab, UCLA Neurology, Alzheimer's Los Angeles, and community leaders are working together bridging the gap between health disparities ...
1 min read
Article
Healthy Body. Healthy Mind.
In the Summer Edition of Keiro Connect, Dr. Kevin Bickart discussed physical activity, including dancing, to improve brain health and prevent dementia ...
1 min read
Article
An In-Depth Interview on Various Neurodegenerative Diseases
Dr. Keith Vossel was interviewed by Dr. Marc Siegel from Doctor Radio/Sirius XM about a wide spectrum of neurodegenerative diseases, including ...
1 min read